REG - CVS Group plc - Exercise of Options and PDMR Dealing

CVSAnnouncement

20/12/2022 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221220:nRST3776Ka&default-theme=true

RNS Number : 3776K  CVS Group plc  20 December 2022

20 December 2022

 

CVS Group Plc

("CVS", the "Company" or the "Group")

Exercise of Options, PDMR Dealing, EBT Share Purchase and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services,
announces that on 19 December 2022, options over a total of 115,280 new
Ordinary shares of 0.2 pence each (the "New shares") were exercised under the
CVS Group 2019 Long Term Incentive Plan ("LTIP 13"), at an exercise price of
0.2 pence.

 

Richard Fairman, Chief Executive Officer, Ben Jacklin, Chief Operating
Officer, and Robin Alfonso, Chief Financial Officer, exercised options over
46,296, 27,778 and 15,278 Ordinary shares of 0.2p each in the Company
("Ordinary shares") respectively.  The balance of the options was exercised
by certain other employees of the Company.

 

On 19 December 2022, the Company was notified by JTC Employer Solutions
Trustee Limited, the trustee of the CVS Group Employee Benefit Trust (the
"EBT"), that the EBT had purchased a total of 60,944 of the New shares from
LTIP 13 option-holders at a volume-weighted average price of £20.01 per
Ordinary share.  This included the purchase of shares by the EBT from Richard
Fairman, Ben Jacklin and Robin Alfonso to meet the costs of exercise incurred
by them as PDMR option-holders, including personal taxation, as set out below:

 

Name
Number of shares sold to EBT                    Price

Richard Fairman
22,159
£20.01

Ben
Jacklin
13,295
£20.01

Robin
Alfonso
7,313
£20.01

 

 

The New shares purchased by the EBT are intended to be used to satisfy the
exercise of share options by employees.  The EBT is a discretionary trust for
the benefit of the Company's employees, including the Directors of the
Company.  The purchase of the New shares by the EBT has been funded from the
Company's existing cash reserves.  Following this transaction, a total of
60,968 Ordinary shares are held by the EBT, representing approximately 0.086%
of the Company's total voting rights.

 

Application has been made for the New shares, which rank pari passu in all
respects with the Company's existing Ordinary shares, to be admitted to
trading on AIM, which is expected to occur on 22 December 2022.

 

Following the issue of the New shares, the Company has a total issued share
capital of 71,271,971 Ordinary shares each carrying one voting right.  The
Company holds no Ordinary shares in treasury. Therefore, following the issue
of the New shares, the total number of voting rights in the Company will be
71,271,971.  This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the Company under the
FCA's Disclosure Guidance and Transparency Rules.

 

 

Following their respective option exercises, their sales of a portion of the
New shares arising and admission of the New shares, the Executive Directors
hold a beneficial interest in the following Ordinary shares in the Company:

 

Name
Number of shares           Percentage interest in the Company

Richard Fairman
55,981
0.079%

Ben
Jacklin
22,384
0.031%

Robin
Alfonso
11,442
0.016%

 

The notification below, made in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail.

 

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Jenny Farrer, Company Secretary

 

Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

   Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey
Pelham-Lane
 
 +44 (0)7733 124 226

Ginny
Pulbrook
+44 (0)7961 315 138

   Toby
Strong
                                             +44
(0)7789 151 644

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Richard Fairman

 2    Reason for the notification

 a)   Position/status                                              Chief Executive Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    i)          Exercise of options under LTIP 13

                                                                   ii)          Sale of Ordinary shares arising from exercise

 c)   Price(s) and volume(s)

Price(s)                         Volume(s)

                                                                   i)    Exercise price of 0.2p     46,296

                                                                                                    22,159

                                                                   ii)    2,000.77p

 

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      19 December 2022

 f)   Place of the transaction                                     i)          Outside a trading venue

                                                                   ii)          London Stock Exchange, AIM.

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

e)

 

Date of the transaction

 

 

19 December 2022

f)

 

Place of the transaction

 

 

i)          Outside a trading venue

ii)          London Stock Exchange, AIM.

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Ben Jacklin

 2    Reason for the notification

 a)   Position/status                                              Chief Operating Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    i)          Exercise of options under LTIP 13

                                                                   ii)          Sale of Ordinary shares arising from exercise

 c)   Price(s) and volume(s)                                       Price(s)                         Volume(s)

                                                            i)    Exercise price of 0.2p     27,778

                                                                                                    13,295

                                                                   ii)    2,000.77p

 

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      19 December 2022

 f)   Place of the transaction                                     i)          Outside a trading venue

                                                                   ii)          London Stock Exchange, AIM.

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

e)

 

Date of the transaction

 

 

19 December 2022

f)

 

Place of the transaction

 

 

i)          Outside a trading venue

ii)          London Stock Exchange, AIM.

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Robin Alfonso

 2    Reason for the notification

 a)   Position/status                                              Chief Financial Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    i)          Exercise of options under LTIP 13

                                                                   ii)          Sale of Ordinary shares arising from exercise

 c)   Price(s) and volume(s)                                       Price(s)                         Volume(s)

                                                            i)    Exercise price of 0.2p     15,278

                                                                                                    7,313

                                                                   ii)    2,000.77p

 

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      19 December 2022

 f)   Place of the transaction                                     i)          Outside a trading venue

                                                                   ii)          London Stock Exchange, AIM.

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

e)

 

Date of the transaction

 

 

19 December 2022

f)

 

Place of the transaction

 

 

i)          Outside a trading venue

ii)          London Stock Exchange, AIM.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEEAKAEADXAFFA